Stay updated on Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Funding information was added under Other Study ID Numbers to indicate NIH support, and the site footer shows a new revision tag (v3.6.6) replacing the previous version.
    Difference
    0.1%
    Check dated 2026-08-29T18:50:44.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, representing a minor maintenance/update to the page’s versioning. No study content is implied to have changed.
    Difference
    0.0%
    Check dated 2026-08-08T15:52:00.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.3 to v3.6.4, reflecting a small publishing/backend update to the study record page.
    Difference
    0.0%
    Check dated 2026-07-25T07:40:22.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision tag on the page has been updated from v3.6.2 to v3.6.3, signaling a newer version of the study entry. This change represents an update to the page's version identifier rather than a modification to the study data or content.
    Difference
    0.0%
    Check dated 2026-07-03T22:09:07.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, indicating a minor update to the page template or rendering framework.
    Difference
    0.0%
    Check dated 2026-06-26T19:49:50.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The study page now indicates that recruitment is closed, signaling that enrollment has ended; it also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the site version to v3.6.0, with a minor formatting change to the Intervention/Treatment label.
    Difference
    0.4%
    Check dated 2026-06-12T12:38:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.